Hot answers tagged

9

I'm honestly not sure how one could answer this question. The CGDEV paper you've quoted that from used 3 different methods to estimate the excess deaths in India... because there's no official data on those, due to the inefficiencies of India's data collection system. Even the (centralized) data that's needed for best estimates of excess deaths in India is ...


5

On the suggestion of a commenter: Yes, They Did, But. The question as asked in the title is "did a participant in the vaccine trial develop acute encephalopathy?" In the original posted article, there was a link to a sciencemag article that stated it fairly definitively: The trial participant, a 40-year-old business consultant from Chennai, sent ...


Only top voted, non community-wiki answers of a minimum length are eligible